Tarsa Therapeutics, Inc.   Report issue

For profit Phase 3
Founded: Philadelphia PA United States (2009)
Status: Acquired by R-Pharm (2019)

Organization Overview

First Clinical Trial
2009
NCT00620854
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Chief Medical Officer - Tarsa Therapeutics, Inc.